Clinical Trials Sponsored by Akros Pharma Inc
Total 2366 results
-
UMN Pharma Inc.Completed
-
UMN Pharma Inc.CompletedInfluenza | VaccineJapan
-
ZS Pharma, Inc.Completed
-
Astellas Pharma IncCompletedLiver TransplantationKorea, Republic of
-
Astellas Pharma IncCompletedKIDNEY TRANSPLANTATIONItaly
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedFungemia | Fungal InfectionsChina
-
Astellas Pharma IncCompletedDe Novo Kidney TransplantationBelgium, France, Netherlands, Spain, Sweden, Austria, Italy, Germany, United Kingdom, Hungary, Poland, Czech Republic
-
Astellas Pharma IncCompletedOveractive BladderThailand
-
Astellas Pharma IncCompletedKidney TransplantationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDiarrhea-predominant Irritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedDiarrhea-predominant Irritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedHealthy | Urine Phosphorus ExcretionJapan
-
Astellas Pharma IncCompletedProstate Cancer | TumorsUnited States
-
Astellas Pharma IncCompletedPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male SubjectsJapan
-
Nexgen Pharma, IncCompleted
-
Zurex Pharma, Inc.CompletedSurgical Site InfectionUnited States
-
Astellas Pharma IncCompletedFunctional Dyspepsia | DyspepsiaJapan
-
Oncozyme Pharma Inc.CompletedNon-small Cell Lung CancerPoland
-
Oncozyme Pharma Inc.Completed
-
Astellas Pharma IncCompletedIrritable Bowel SyndromeJapan
-
Astellas Pharma IncCompletedPost Operative PainJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedCandidemia | CandidiasisBelgium, France, Germany, Spain, United States, India, Canada, Brazil, Switzerland, Austria, Croatia, Netherlands, Poland, Czech Republic, United Kingdom
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDermatitis, Atopic | Eczema, AtopicFrance, Germany, United Kingdom, Spain, Belgium, Netherlands, Finland, Poland, Ireland, Hungary, Denmark, Latvia
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedAtopic DermatitisAustralia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedPatients With Traumatic Pain, Post-surgical Pain and Tooth Extract PainJapan
-
Astellas Pharma IncCompletedDermatitis, AtopicUnited Kingdom, Finland, Ireland, Canada, Latvia
-
Astellas Pharma IncCompletedUlcerative ColitisJapan
-
Astellas Pharma IncCompletedRheumatoid ArthritisJapan
-
Astellas Pharma IncCompletedCandidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal CandidiasisUnited States
-
Astellas Pharma IncCompletedCandidiasis, OralArgentina, South Africa, Brazil, Peru
-
Astellas Pharma IncCompletedSleep Initiation and Maintenance DisordersJapan
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Astellas Pharma IncCompletedKidney TransplantationNetherlands
-
Astellas Pharma IncCompletedTransplantationNetherlands, Spain, Germany, United Kingdom, Poland, France
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1585United States
-
Antares Pharma Inc.CompletedRheumatoid Arthritis (RA)United States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronNetherlands
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Canada